Weprepared new7-hydroxyguanine derivatives, 7-hydroxyguanosine 5'-monophosphate and 7V2-tetrahydropyranyl-7-hydroxyguanine, and compared biological activities of 7-hydroxyguanine derivatives including nucleosides acquired previously. 7-Hydroxyguanine and its nucleotide inhibited the focus formation of Rous sarcoma virus. Antitumor activities of these derivatives against mouse leukemia L1210 were not so different from one another. Anti-proliferative activities of the derivatives on various humancell lines were significantly different from one another.
HPLC Analysis
The HPLCinstrumention consisting of the Nihonbunko V system and YMCpack A-612 column 6 x 150mm(Yamamura Chemical Co., Ltd.) was used. The mobile phase was 95mMNH4H2PO4buffer (pH 4.0) containing 5% methanol at a flow rate of 1.0 ml/minute. 7-Hydroxyguanosine 5'-monophosphate, 7V2-tetrahydropyranyl-7-hydroxyguanine and 7-hydroxyguanine were detected by UVabsorption at 254 nm and their retention times were 8.9, 7. 1 and 4.4minutes, respectively.
Preparation of 7-Hydroxyguanosine 5/-Monophosphate Disodium Salt (1) 7-Hydroxyguanine (180mg) and 5-phospho-a-D-ribosyldiphosphate sodium salt (1,300mg ) were dissolved in 350ml of 50mM Tris buffer (pH 7.8) containing 12.5mM dithiothreitol and 2.5mM MgCl2. The reaction was started by the addition of 50,000 u of hypoxanthine phosphoribosyltransferase. After incubation for 14 hours at 30°C, 70% of 7-hydroxyguanine was converted to 7-hydroxyguanosine 5'-monophosphate.
The reaction mixture was applied to a column of DEAE-Sephadex A-25 (HCO3~, 200 ml) and eluted with 0.2m NH4HCO3. The eluate was evaporated in vacuo to 3ml. The concentrate was applied to the column of Sephadex LH-20 (600 ml) and developed with 20 mMNH4OH.The eluate was evaporated and dried, yielding white powder of crude 7-hydroxyguanosine 5'-monophosphate (280 mg). The white powder (160mg) was dissolved in 1.2ml of water. To this solution 80/^1 of 1 M NaOHand 3.2ml ofethanol were added. After 16 hours in the refrigerator 1 precipitated as colorless crystals (127.5 mg).
Preparation of A^-Tetrahydropyranyl-T-hydroxyguanine (2) 7-Hydroxyguanine (1,000mg) was dissolved in 25ml of DMSOwith 2ml of hydrogen chloride in dry dioxane (6.0m). 2,3-Dihydropyran (1.12ml) was added to the stirred solution. The mixture was stirred at 15°C under argon atmosphere for 4 hours. After neutralization with anhydrous NaHCO3 (1,200 mg), ethyl acetate (250 ml) and hexane (250 ml) were added to the solution. The resulting precipitate was filtered off, dried in vacuo and purified by silica gel column chromatography (CHC13-methanol, 10 : 1). The eluate was evaporated and dried, yielding a white powder of A^-tetrahydropyranyl-T-hydroxyguanine (270mg).
Anti-rous Sarcoma Virus Assay
The effects of 7-hydroxyguanine and its derivatives on growth of chick embryonic fibroblast were determined by trypan blue staining method. Focus-forming assay for Rous sarcoma virus (RSV) was carried out according to the procedure descrived by Sambrook and Pollack7). Laboratories, Rockville, MD).
In Vitro Cell Proliferation Assay 0.1 ml aliquots of tumor cells (l~2 x 104/ml) were dispensed into 96-well microtiter plates in their cell-specific media and serial 2-fold dilutions of 7-hydroxyguanine derivatives were added to a final volume of 0.2 ml, respectively. Cells were incubated at 37°C for 5~7 days in a 5% CO2 -humidified airincubator.
The methylene blue dye assay was performed on adherent tumor cell lines. Adherent tumor cells were fixed with 2.5 % glutaraldehyde and stained with 0.05% methylene blue for 10minutes. After the cells were thoroughly washed with tap water, the methylene blue dye was eluted with 0.1 ml of 0.33 m HC1. The absorbance at 655 nm was measured on a Titertek Multiscan photometer (Flow Laboratories).
Anti-proliferative activity to non adherent tumor cells Colo320DMand CCRF-CEM was measured by colorimetric assay, which is based on the ability ofmitochondrial enzymes to transform MTTtetrazolium salt into a formazan8). Tetrazolium salt (MTT) (Sigma Chemical Company) was prepared fresh at 5 mg/ml in phosphate-buffered saline in a darkened tube. The MTTwas added to all wells of the assay plates in a 20-jul volume. Then, plates were incubated at 37°C for 4 hours. At the end of the MTTincubation, 0.1 ml aliquots of the medium were removed by aspiration and 0.1 ml of acidified isopropyl alcohol (0.4m HC1 in 2-propanol) was added to solubilize the MTTformazan. After the complete solubilization of the MTT formazan using a multichannel pipet, the absorbance was measured at 540nm on a Titertek Multiscan photometer.
Antitumor Assay Lymphoidleukemia LI210, 105 cells per mouse were inoculated intraperitoneally into female mice (BDFXstrain 1 8~22 g weight). 7-Hydroxyguanine derivatives were administered intraperitoneally 24 hours after the tumor inoculation. The treatment was done once daily for 5 days. Table 1 .
Positive ion FAB-MSof 1 gave a base ion at m/z 424 (M +H)+. Elemental analysis showed 1 to form a pentahydrate. Proton magnetic resonance study indicated that 7-hydroxyguanosine does not have an 8-H signal in aqueous solution6), but 1 has an 8-H signal at 8.47ppm in aqueous solution because the 5'-phosphoryl group has a specific deshielding effect on the 8-H proton of guanine nucleotides9). The 13C NMRstudy indicates that the resonance ofC-4' is split as a result of *3C-3*P scalar coupling (Jcp = 6.8 Hz).
To prepare new derivatives which we will not be able to prepare by enzymatic methods, we have tried chemical modifications of 7-hydroxyguanine. Most attempts failed to yield bio-active derivatives. In many cases, 7-hydroxyguanine was substituted by the agents at the 8-position. The derivatives substituted at the 8-position lost antibacterial activity on synthetic mediumand antitumor activity against mouse leukemia L1210.
2,3-Dihydropyran gave an active derivative, 7V2-tetrahydropyranyl-7-hydroxyguanine (2) (Fig. 2) . Biological Activities As shown in Table 2 , 7-hydroxyguanine and 1 inhibited the focus formation of RSV. In this system, 7-hydroxyguanosine did not show anti-viral activity because of its high toxicity to host cells. The difference in toxicity to chicken embryonic fibroblasts (CEF) among these derivatives suggest a possibility of differential metabolism of 7-hydroxyguanine derivatives in the cell. Hasobe et al.
reported the anti-viral activity of guanine 7-7V-oxide, a tautomer of 7-hydroxyguanine, against herpes virus and rhabdo virus which were infectious to salmonids10). We showed that 7-hydroxyguanine and its nucleotide inhibited the focus formation of Table 4 . Antitumor activity of7-hydroxyguanine derivatives against mouse leukemia LI210.
T/C (%)b oncogenic retro virus. Further study will be necessary to clarify the differential effects of 7-hydroxyguanine derivatives on the metabolism of host cells and viruses.
As shown in Table 3 , 7-hydroxyguanine derivatives have anti-proliferative activity on various human cell lines. In the tested cell lines, G361 (malignant melanoma) was most sensitive to these compounds. 7 -Hydroxyguanosine was more effective to A549 (lung carcinoma) than 7-hydroxyguanine.
7-
Hydroxyguanosine was less toxic to normal type cell line, MRC-5(embryonic-lung-diploid cell). Jackson et al. reported that 7-hydroxyguanine did not inhibit the rate of synthesis of DNAand RNAin mouse leukemia L1210 cells11*. They showed that the major effect of 7-hydroxyguanine on L1210 cells was inhibition of protein biosynthesis. Hasobe et al. reported that 7-hydroxyguanine might be regarded as an analog of 7-methylguanosine in the cap structure of eucaryotic and viral m-RNA12). It is interesting to clarify the mechanismof action of 7-hydroxyguanine derivatives on eucaryotic cells and viruses.
As shown in Table 4 , 1 and 2 have antitumor activity against mouse leukemia, but the effects are not superior to that of 7-hydroxyguanine.
The acute toxicity of 1 and 2 were determined in male mice (ICR strain) by single intraperitoneal administration, the LD50 values of 1 and 2 are in the range 150~300 and 160~320mg/kg, respectively. APR. 1990 In the in vivo L1210-system, 7-hydroxy-2'-deoxyguanosine was slightly superior to other derivatives6*, but anti-proliferative activities of 7-hydroxyguanine derivatives on humancancer cell lines were significantly different from one another. In vivo study with humancancer cells will be important to further evaluation of 7-hydroxyguanine derivatives.
